217 related articles for article (PubMed ID: 18609267)
1. Treatment outcome of day-time urinary incontinence in children.
Hagstroem S; Rittig N; Kamperis K; Mikkelsen MM; Rittig S; Djurhuus JC
Scand J Urol Nephrol; 2008; 42(6):528-33. PubMed ID: 18609267
[TBL] [Abstract][Full Text] [Related]
2. Timer watch assisted urotherapy in children: a randomized controlled trial.
Hagstroem S; Rittig S; Kamperis K; Djurhuus JC
J Urol; 2010 Oct; 184(4):1482-8. PubMed ID: 20727552
[TBL] [Abstract][Full Text] [Related]
3. Comparison and characteristics of children successfully treated for daytime urinary incontinence.
Jessen AS; Hagstroem S; Borch L
J Pediatr Urol; 2022 Feb; 18(1):24.e1-24.e9. PubMed ID: 34930690
[TBL] [Abstract][Full Text] [Related]
4. Transcutaneous electrical nerve stimulation for refractory daytime urinary urge incontinence.
Hagstroem S; Mahler B; Madsen B; Djurhuus JC; Rittig S
J Urol; 2009 Oct; 182(4 Suppl):2072-8. PubMed ID: 19695629
[TBL] [Abstract][Full Text] [Related]
5. Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder.
Van Arendonk KJ; Austin JC; Boyt MA; Cooper CS
Urology; 2006 May; 67(5):1049-53; discussion 1053-4. PubMed ID: 16698366
[TBL] [Abstract][Full Text] [Related]
6. Voiding school as a treatment for daytime incontinence or enuresis: Assessing the effectiveness of intervention by measuring changes in wetting episodes.
Saarikoski A; Koppeli R; Taskinen S; Axelin A
J Pediatr Urol; 2018 Jun; 14(3):256.e1-256.e7. PubMed ID: 29452905
[TBL] [Abstract][Full Text] [Related]
7. Urotherapy in children: quantitative measurements of daytime urinary incontinence before and after treatment according to the new definitions of the International Children's Continence Society.
Mulders MM; Cobussen-Boekhorst H; de Gier RP; Feitz WF; Kortmann BB
J Pediatr Urol; 2011 Apr; 7(2):213-8. PubMed ID: 20541978
[TBL] [Abstract][Full Text] [Related]
8. Voiding school for children with idiopathic urinary incontinence and/or bladder dysfunction.
Glad Mattsson G; Brännström M; Eldh M; Mattsson S
J Pediatr Urol; 2010 Oct; 6(5):490-5. PubMed ID: 19945349
[TBL] [Abstract][Full Text] [Related]
9. Initial trial of timed voiding is warranted for all children with daytime incontinence.
Allen HA; Austin JC; Boyt MA; Hawtrey CE; Cooper CS
Urology; 2007 May; 69(5):962-5. PubMed ID: 17482943
[TBL] [Abstract][Full Text] [Related]
10. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
Almodhen F; Capolicchio JP; Jednak R; El Sherbiny M
J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
[TBL] [Abstract][Full Text] [Related]
11. Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial.
Marschall-Kehrel D; Feustel C; Persson de Geeter C; Stehr M; Radmayr C; Sillén U; Strugala G
Eur Urol; 2009 Mar; 55(3):729-36. PubMed ID: 18502028
[TBL] [Abstract][Full Text] [Related]
12. Adequate fluid intake, urinary incontinence, and physical and/or intellectual disability.
Van Laecke E; Raes A; Vande Walle J; Hoebeke P
J Urol; 2009 Oct; 182(4 Suppl):2079-84. PubMed ID: 19695633
[TBL] [Abstract][Full Text] [Related]
13. Do holding exercises or antimuscarinics increase maximum voided volume in monosymptomatic nocturnal enuresis? A randomized controlled trial in children.
Van Hoeck KJ; Bael A; Van Dessel E; Van Renthergem D; Bernaerts K; Vandermaelen V; Lax H; Hirche H; van Gool JD
J Urol; 2007 Nov; 178(5):2132-6. PubMed ID: 17870123
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A in combination with standard urotherapy for children with dysfunctional voiding.
Petronijevic V; Lazovic M; Vlajkovic M; Slavkovic A; Golubovic E; Miljkovic P
J Urol; 2007 Dec; 178(6):2599-602; discussion 2602-3. PubMed ID: 17945299
[TBL] [Abstract][Full Text] [Related]
15. Correlation between uroflowmetry parameters and treatment outcome in children with dysfunctional voiding.
Vesna Z; Milica L; Marina V; Andjelka S; Lidija D
J Pediatr Urol; 2010 Aug; 6(4):396-402. PubMed ID: 19850529
[TBL] [Abstract][Full Text] [Related]
16. [Non-neurogenic lower urinary tract dysfunction].
Skobejko-Włodarska L
Pol Merkur Lekarski; 2008; 24 Suppl 4():131-7. PubMed ID: 18924526
[TBL] [Abstract][Full Text] [Related]
17. Clinical differences in daytime wetting subtypes: urge incontinence and postponed voiding.
Kuhn S; Natale N; Siemer S; Stoeckle M; von Gontard A
J Urol; 2009 Oct; 182(4 Suppl):1967-72. PubMed ID: 19695641
[TBL] [Abstract][Full Text] [Related]
18. The evaluation of combined standard urotherapy, abdominal and pelvic floor retraining in children with dysfunctional voiding.
Vesna ZD; Milica L; Stanković I; Marina V; Andjelka S
J Pediatr Urol; 2011 Jun; 7(3):336-41. PubMed ID: 21527231
[TBL] [Abstract][Full Text] [Related]
19. Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin.
Van Arendonk KJ; Knudson MJ; Austin JC; Cooper CS
Urology; 2006 Oct; 68(4):862-5. PubMed ID: 17070368
[TBL] [Abstract][Full Text] [Related]
20. Effects of transcutaneous neuromodulation (TENS) on overactive bladder symptoms in children: a randomized controlled trial.
Sillén U; Arwidsson C; Doroszkiewicz M; Antonsson H; Jansson I; Stålklint M; Abrahamsson K; Sjöström S
J Pediatr Urol; 2014 Dec; 10(6):1100-5. PubMed ID: 24881806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
